Twist Bioscience (TWST) Reports Q2 2026 Financial Results
Published on 5/10/2026
AI Summary
Summarized by AI from the source belowTwist Bioscience Corporation (TWST) reported its financial results for Q2 2026. The company achieved revenue growth of 10% year-over-year, reaching $30 million. The gross profit margin for the quarter was reported at 65%. This performance indicates a steady demand for their synthetic DNA products, which could positively influence market confidence in TWST's future growth.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
